A detailed history of Quest Partners LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 19,553 shares of BMEA stock, worth $122,792. This represents 0.02% of its overall portfolio holdings.

Number of Shares
19,553
Previous 3,112 528.31%
Holding current value
$122,792
Previous $14 Million 1310.2%
% of portfolio
0.02%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$4.23 - $10.1 $69,545 - $166,054
16,441 Added 528.31%
19,553 $197 Million
Q2 2024

Aug 06, 2024

BUY
$4.14 - $15.3 $8,288 - $30,630
2,002 Added 180.36%
3,112 $14 Million
Q1 2024

May 09, 2024

SELL
$13.92 - $19.5 $59,995 - $84,045
-4,310 Reduced 79.52%
1,110 $16.6 Million
Q4 2023

Feb 09, 2024

BUY
$8.37 - $19.8 $45,365 - $107,316
5,420 New
5,420 $78.7 Million

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $184M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.